In conclusions, CCE treatment effectively attenuated asthmatic responses including eosinophilia, AHR, cytokine production, OVA-specific IgE, eosinophilic inflammation, and mucus secretion in OVA-exposed model. The gene discussed is AHR; the disease is Increased total eosinophil count.